D-Dimer: A Potential Solution to Problems of Cancer Screening, Surveillance, and Prognosis Assessment
| Autor: | Pousette Hamid, Archana Sreekantan Nair, Ransirini Wijeratne Fernando, Mushrin Malik, Janan Illango, Rajvi Gor, Nabeel A Siddiqui |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry General Engineering Cancer Hematology Plasma levels 030204 cardiovascular system & hematology medicine.disease Malignancy Cancer recurrence Cancer prognosis 03 medical and health sciences 0302 clinical medicine Internal medicine Cancer screening D-dimer Internal Medicine medicine cancer business d-dimer 030217 neurology & neurosurgery malignancy |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | Research has established a direct link between the plasma level of D-dimer and underlying malignancy. D-dimer has a strong association with the detection and prognosis of several cancers. For these reasons, this literature review aimed to evaluate the usefulness of elevated D-dimer levels in the initial screening of cancer, cancer recurrence surveillance, and for use as a cancer prognostic tool. A search of PubMed up to February 1, 2021, was carried out by reviewers. This literature review includes studies investigating the relationship between pretreatment plasma D-dimer levels and cancer. From the findings, pretreatment D-dimer levels can assist with cancer screening and prognosis assessment. Pretreatment plasma D-dimer levels can function as an effective cancer recurrence control. Elevated pre-treatment plasma D-dimer concentration is valuable in facilitating cancer screening, predicting an augmented risk of cancer recurrence, and anticipating a worse cancer prognosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|